Femme et Homme
- | Pays :
- United States
- United Kingdom
- France
- ...
- | Organes : -
- | Spécialités : -
Extrait
The aim of this combined, two part study is to evaluate the safety and glucose lowering effects of GSK256073 when administered to diabetic subjects for 12 weeks.
Critère d'inclusion
- Diabetes Mellitus, Type 2